LAUSR

Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms

Sign Up to like & get
recommendations!
1 Published in 2022 at "Pharmaceutics"

DOI: 10.3390/pharmaceutics14020331

Abstract: In gliomas, casein kinase 2 (CK2) plays a dominant role in cell survival and tumour invasiveness and is upregulated in many brain tumours. Among CK2 inhibitors, benzimidazole and isothiourea derivatives hold a dominant position. While… read more here.

Keywords: among promising; promising therapeutic; ck2 inhibitors; inhibiting ck2 ... See more keywords